Oscar Health's Growth Accelerates Amid Medicare Reimbursement Increase
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 25 2025
0mins
Should l Buy OSCR?
Oscar Health Inc's stock rose 4.64% as it reached a 20-day high, reflecting strong investor interest in the company's growth potential.
The stock's upward movement is attributed to the recent announcement of a 2.48% increase in Medicare Advantage reimbursement rates for 2027, which is expected to provide over $13 billion in additional payments. This significant financial boost enhances Oscar Health's outlook and investor confidence, especially as the company targets a revenue increase of 60% to 62% for 2026, aiming for $18.7 billion to $19 billion in total revenue.
The implications of this growth are substantial, as Oscar Health's ability to effectively manage costs and expand its member base positions it favorably in the competitive health insurance market. The upcoming earnings report on May 6 is also anticipated to further influence stock performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to rise
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 15.590
Low
11.00
Averages
15.75
High
25.00
Current: 15.590
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health Stock Gains as Investor Sentiment Improves
- Industry Confidence Rebound: Oscar Health's stock gained momentum in afternoon trading on April 11, 2026, indicating a reduction in investor pessimism about the industry, potentially laying the groundwork for future growth.
- Positive Market Reaction: The uptick in stock prices, driven by improved investor sentiment, may attract more capital inflows, thereby strengthening the company's market position and financial stability.
- Investor Sentiment Shift: The renewed confidence in Oscar Health likely stems from a reassessment of the company's business model and market outlook, providing support for future strategic development.
- Potential Growth Opportunities: As industry sentiment improves, Oscar Health may gain more opportunities in future market competition, further driving its business expansion and profitability enhancement.
See More
Oscar Health Stock Gains Momentum as Investor Sentiment Improves
- Industry Confidence Rebound: Oscar Health (NYSE: OSCR) stock is gaining traction, indicating a reduction in investor pessimism about the industry, which could lay the groundwork for future growth opportunities.
- Investor Attention: Although Oscar Health did not make it onto The Motley Fool Stock Advisor's list of the top 10 stocks, it continues to attract investor interest, reflecting market recognition of its potential value.
- Market Performance Comparison: The Motley Fool Stock Advisor reports an average return of 975%, significantly outperforming the S&P 500's 193%, highlighting the importance of careful stock selection for potential returns.
- Future Outlook: With advancements in AI technology, there is increasing attention on related companies, and Oscar Health may gain more prominence in future investment portfolios, particularly in the innovative healthcare sector.
See More
Investment Opportunities in Health Insurance Sector
- Industry Profitability Potential: The health insurance sector presents long-term investment appeal due to the continuous rise in healthcare spending, which reached $5.3 trillion in the U.S. by 2024, indicating the industry's durability and profitability.
- UnitedHealth Group Performance: As the largest health insurer, UnitedHealth Group reported $448 billion in revenue for 2025, and despite challenges like cyberattacks and rising healthcare costs, its net income has been steadily growing, showcasing its resilience in market leadership.
- Oscar Health's Rapid Growth: Oscar Health added 3.4 million members during the 2026 open enrollment period, up from under 1 million at the end of 2021, indicating strong growth potential in the ACA market, despite a medical loss ratio of 87.4%.
- Optimistic Market Outlook: With the aging U.S. population and advancements in medical technology, healthcare costs are expected to continue rising, prompting investors to focus on companies that can effectively manage costs for long-term profitability.
See More
Investment Opportunities in Healthcare Stocks
- Market Recovery Potential: Despite healthcare stocks like UnitedHealth Group experiencing a 50% drop from their highs, they are expected to rebound in 2026, reflecting the durable value of the industry and the trend of increasing healthcare expenditures.
- Profitability Analysis: UnitedHealth Group reported $448 billion in revenue for 2025, and although net income fell 41% year-over-year due to cyberattacks and rising medical costs, its price-to-earnings ratio of 23.5 indicates potential for future improvement.
- Innovative Business Model: Oscar Health saw enrollment surge to 3.4 million in 2026, up from under 1 million in 2021, demonstrating that its disruptive business model is gaining traction in the ACA marketplace.
- Industry Spending Trends: U.S. healthcare spending has skyrocketed from $74 billion in 1970 to $5.3 trillion in 2024, and this trend is expected to continue, suggesting that as long as insurance companies manage costs effectively, they can achieve long-term profitability.
See More
Oscar Health Stock Rises for Sixth Consecutive Day
- Medicare Reimbursement Increase: Oscar Health's stock surged 12.88% to close at $14.64 on Wednesday, following the announcement that Medicare Advantage reimbursement rates will rise to 2.48% in 2027 from just 0.09% in January, translating to over $13 billion in additional payments, significantly enhancing its financial outlook.
- Strong Market Performance: The stock's sixth consecutive day of gains reflects investor confidence in Oscar Health's growth potential, particularly in light of the increased reimbursement rates for Medicare plans, which are expected to bolster its competitive position in the market.
- Revenue Growth Target: Oscar Health is targeting a revenue increase of 60% to 62% for 2026, aiming for a range of $18.7 billion to $19 billion, compared to $11.7 billion in 2025, which will provide substantial funding for expansion and innovation initiatives.
- Earnings Report Schedule: The company is set to announce its first-quarter earnings before the market opens on May 6, with a conference call to discuss financial and operational highlights, and investor anticipation surrounding this report may further influence stock price movements.
See More
Oscar Health CEO Boosts Market Confidence with $12M Stock Purchase
- CEO Stock Purchase: Oscar Health's CEO Mark Bertolini purchased nearly $12 million worth of company shares on Wednesday morning, demonstrating strong confidence in the firm by acquiring 1 million shares at $11.92 each, totaling approximately $11.9 million.
- Increased Stake: This transaction increased Bertolini's stake in Oscar Health by 11%, bringing his total to 10.2 million shares, thereby reinforcing his control and trust in the company.
- Stock Price Surge: Following Bertolini's stock purchase, Oscar Health's shares rose about 7% on Tuesday, coinciding with the U.S. government's announcement of a 2.5% increase in reimbursements for Medicare Advantage health plans for 2027, surpassing previous proposals.
- Optimistic Market Outlook: Despite macroeconomic challenges anticipated in 2025, Oscar Health maintains an optimistic outlook, with expectations for significant price discovery in 2026, enhancing market confidence in its long-term growth potential.
See More
Oscar Health Stock Gains as Investor Sentiment Improves
- Industry Confidence Rebound: Oscar Health's stock gained momentum in afternoon trading on April 11, 2026, indicating a reduction in investor pessimism about the industry, potentially laying the groundwork for future growth.
- Positive Market Reaction: The uptick in stock prices, driven by improved investor sentiment, may attract more capital inflows, thereby strengthening the company's market position and financial stability.
- Investor Sentiment Shift: The renewed confidence in Oscar Health likely stems from a reassessment of the company's business model and market outlook, providing support for future strategic development.
- Potential Growth Opportunities: As industry sentiment improves, Oscar Health may gain more opportunities in future market competition, further driving its business expansion and profitability enhancement.
See More
Oscar Health Stock Gains Momentum as Investor Sentiment Improves
- Industry Confidence Rebound: Oscar Health (NYSE: OSCR) stock is gaining traction, indicating a reduction in investor pessimism about the industry, which could lay the groundwork for future growth opportunities.
- Investor Attention: Although Oscar Health did not make it onto The Motley Fool Stock Advisor's list of the top 10 stocks, it continues to attract investor interest, reflecting market recognition of its potential value.
- Market Performance Comparison: The Motley Fool Stock Advisor reports an average return of 975%, significantly outperforming the S&P 500's 193%, highlighting the importance of careful stock selection for potential returns.
- Future Outlook: With advancements in AI technology, there is increasing attention on related companies, and Oscar Health may gain more prominence in future investment portfolios, particularly in the innovative healthcare sector.
See More
Investment Opportunities in Health Insurance Sector
- Industry Profitability Potential: The health insurance sector presents long-term investment appeal due to the continuous rise in healthcare spending, which reached $5.3 trillion in the U.S. by 2024, indicating the industry's durability and profitability.
- UnitedHealth Group Performance: As the largest health insurer, UnitedHealth Group reported $448 billion in revenue for 2025, and despite challenges like cyberattacks and rising healthcare costs, its net income has been steadily growing, showcasing its resilience in market leadership.
- Oscar Health's Rapid Growth: Oscar Health added 3.4 million members during the 2026 open enrollment period, up from under 1 million at the end of 2021, indicating strong growth potential in the ACA market, despite a medical loss ratio of 87.4%.
- Optimistic Market Outlook: With the aging U.S. population and advancements in medical technology, healthcare costs are expected to continue rising, prompting investors to focus on companies that can effectively manage costs for long-term profitability.
See More
Investment Opportunities in Healthcare Stocks
- Market Recovery Potential: Despite healthcare stocks like UnitedHealth Group experiencing a 50% drop from their highs, they are expected to rebound in 2026, reflecting the durable value of the industry and the trend of increasing healthcare expenditures.
- Profitability Analysis: UnitedHealth Group reported $448 billion in revenue for 2025, and although net income fell 41% year-over-year due to cyberattacks and rising medical costs, its price-to-earnings ratio of 23.5 indicates potential for future improvement.
- Innovative Business Model: Oscar Health saw enrollment surge to 3.4 million in 2026, up from under 1 million in 2021, demonstrating that its disruptive business model is gaining traction in the ACA marketplace.
- Industry Spending Trends: U.S. healthcare spending has skyrocketed from $74 billion in 1970 to $5.3 trillion in 2024, and this trend is expected to continue, suggesting that as long as insurance companies manage costs effectively, they can achieve long-term profitability.
See More
Oscar Health Stock Rises for Sixth Consecutive Day
- Medicare Reimbursement Increase: Oscar Health's stock surged 12.88% to close at $14.64 on Wednesday, following the announcement that Medicare Advantage reimbursement rates will rise to 2.48% in 2027 from just 0.09% in January, translating to over $13 billion in additional payments, significantly enhancing its financial outlook.
- Strong Market Performance: The stock's sixth consecutive day of gains reflects investor confidence in Oscar Health's growth potential, particularly in light of the increased reimbursement rates for Medicare plans, which are expected to bolster its competitive position in the market.
- Revenue Growth Target: Oscar Health is targeting a revenue increase of 60% to 62% for 2026, aiming for a range of $18.7 billion to $19 billion, compared to $11.7 billion in 2025, which will provide substantial funding for expansion and innovation initiatives.
- Earnings Report Schedule: The company is set to announce its first-quarter earnings before the market opens on May 6, with a conference call to discuss financial and operational highlights, and investor anticipation surrounding this report may further influence stock price movements.
See More
Oscar Health CEO Boosts Market Confidence with $12M Stock Purchase
- CEO Stock Purchase: Oscar Health's CEO Mark Bertolini purchased nearly $12 million worth of company shares on Wednesday morning, demonstrating strong confidence in the firm by acquiring 1 million shares at $11.92 each, totaling approximately $11.9 million.
- Increased Stake: This transaction increased Bertolini's stake in Oscar Health by 11%, bringing his total to 10.2 million shares, thereby reinforcing his control and trust in the company.
- Stock Price Surge: Following Bertolini's stock purchase, Oscar Health's shares rose about 7% on Tuesday, coinciding with the U.S. government's announcement of a 2.5% increase in reimbursements for Medicare Advantage health plans for 2027, surpassing previous proposals.
- Optimistic Market Outlook: Despite macroeconomic challenges anticipated in 2025, Oscar Health maintains an optimistic outlook, with expectations for significant price discovery in 2026, enhancing market confidence in its long-term growth potential.
See More
